CHARACTERIZATION OF DOMAIN DELETION AND OR DUPLICATION MUTANTS OF A RECOMBINANT CHIMERA OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA/U-PA)

被引：0
|
作者：
NELLES, L
LIJNEN, HR
VANNUFFELEN, A
DEMARSIN, E
COLLEN, D
机构：
来源：
THROMBOSIS AND HAEMOSTASIS | 1990年 / 64卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：53 / 60
页数：8
相关论文
共 50 条
  • [31] THE KINETICS OF INHIBITION OF TISSUE-TYPE (T-PA) AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) BY 2 MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR 2 (PAI-2) - THE INFLUENCE OF FIBRIN
    THORSEN, S
    MADSEN, B
    RODER, M
    LECANDER, I
    ASTEDT, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 350 - 350
  • [32] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) IS INDEPENDENTLY RELATED TO OUTCOME IN COLORECTAL-CANCER
    SKELLY, MM
    MULCAHY, HE
    CONNELL, T
    TROY, A
    DUGGAN, C
    DUFFY, MJ
    SHEAHAN, K
    ODONOGHUE, DP
    GASTROENTEROLOGY, 1995, 108 (04) : A539 - A539
  • [33] COMPARATIVE THROMBOLYTIC PROPERTIES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA), SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND K1K2PU (A T-PA/U-PA CHIMERA) IN A COMBINED ARTERIAL AND VENOUS THROMBOSIS MODEL IN THE DOG
    LU, HR
    WU, ZM
    PAUWELS, P
    LIJNEN, HR
    COLLEN, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) : 1350 - 1359
  • [34] PHYSICAL EXERCISE INDUCES ENHANCEMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN PLASMA
    DOOIJEWAARD, G
    DEBOER, A
    TURION, PNC
    COHEN, AF
    BREIMER, DD
    KLUFT, C
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (01) : 82 - 86
  • [35] ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) IN ORTHOTOPIC LIVER-TRANSPLANTATION (OLT)
    HIMMELREICH, G
    BREINL, P
    RIESS, H
    NEUHAUS, P
    DOOIJEWAARD, G
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1088 - 1088
  • [36] PHARMACOKINETICS AND SYSTEMIC FIBRINOGENOLYTIC EFFECTS OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) IN HUMANS
    VERSTRAETE, M
    BOUNAMEAUX, H
    DECOCK, F
    VANDEWERF, F
    COLLEN, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 235 (02): : 506 - 512
  • [37] CORONARY ARTERIAL THROMBOLYSIS WITH LOW-DOSE SYNERGISTIC COMBINATIONS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) AND RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (RSCU-PA) FOR ACUTE MYOCARDIAL-INFARCTION
    COLLEN, D
    VANDEWERF, F
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (07): : 431 - 434
  • [38] CORONARY THROMBOLYSIS IN BABOONS AFTER INTRAVENOUS ADMINISTRATION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA)
    FLAMENG, W
    VANDEWERF, F
    VANHAECKE, J
    COLLEN, D
    DEGEEST, H
    CIRCULATION, 1984, 70 (04) : 87 - 87
  • [39] ACCELERATED THROMBOLYSIS USING PULSED INTRATHROMBUS RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA)
    BUCKENHAM, TM
    GEORGE, CD
    CHESTER, JF
    TAYLOR, RS
    DORMANDY, JA
    EUROPEAN JOURNAL OF VASCULAR SURGERY, 1992, 6 (03): : 237 - 240
  • [40] BIOLOGICAL EFFECTS OF INACTIVATION OF THE GENES FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    STASSEN, JM
    BRONSON, R
    COLLEN, D
    MULLIGAN, R
    FIBRINOLYSIS, 1993, 7 : 27 - 28
12345